FDA-Drug2018-10-31Class II

Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01

Teva Pharmaceuticals USA
Hazard

Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.

Sold states
U.S.A. Nationwide including Puerto Rico.
Affected count
53,451 bottles
Manufactured in
1090 Horsham Rd, N/A, North Wales, PA, United States
Products
Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0129-2019

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief